Results 121 to 130 of about 5,151 (200)

Testing for recombinant human erythropoietin [PDF]

, 2008
Delanghe, Joris, Joyner, Michael
core   +1 more source

Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study. [PDF]

Cureus, 2021
Sinha SD, Bandi VK, Reddy BB, Thakur P, Chary S, Talluri L, Kakkunnath S.   +6 more
europepmc   +1 more source

A Randomized Trial of Strategies Using Darbepoetin Alfa To Avoid Transfusions in CKD.

J Am Soc Nephrol, 2021
Toto R, Petersen J, Berns JS, Lewis EF, Tran Q, Tran Q, Weir MR.   +6 more
europepmc   +1 more source

Profile of peginesatide and its potential for the treatment of anemia in adults with chronic kidney disease who are on dialysis

Journal of Blood Medicine, 2012
Ashraf MikhailRenal Unit, Morriston Hospital, Swansea University, Wales, UKAbstract: Peginesatide is a synthetic, dimeric peptide that is covalently linked to polyethylene glycol (PEG).
Mikhail A
doaj  

Phase 3 Randomized Study Comparing Vadadustat with Darbepoetin Alfa for Anemia in Japanese Patients with Nondialysis-Dependent CKD.

J Am Soc Nephrol, 2021
Nangaku M, Kondo K, Kokado Y, Ueta K, Kaneko G, Tandai T, Kawaguchi Y, Komatsu Y.   +7 more
europepmc   +1 more source

The Cost-Effectiveness of Using Epoetin-Beta Versus Darbepoetin-Alfa for the Treatment of Anemia Among Chronic Hemodialysis Patients. [PDF]

Cureus, 2020
AlKharboush H, Alshehri F, Alatwi I, Al Karni K, Alatawi A, Hamdan AM.   +5 more
europepmc   +1 more source

Comparison of Pharmacokinetic, Pharmacodynamic and Tolerability Profiles of CKD-11101, Darbepoetin Alfa (NESP^®) Biosimilar, to Those of NESP^® After a Single Subcutaneous or Intravenous Administration to Healthy Subjects. [PDF]

Drug Des Devel Ther, 2021
Jeon I, Oh J, Kwon YK, Yoon SH, Cho JY, Jang IJ, Yu KS, Lee S.   +7 more
europepmc   +1 more source

Hypoxia-inducible factor prolyl hydroxylase domain inhibitor may maintain hemoglobin synthesis at lower serum ferritin and transferrin saturation levels than darbepoetin alfa. [PDF]

PLoS One, 2021
Ogawa C, Tsuchiya K, Tomosugi N, Maeda K.   +3 more
europepmc   +1 more source

Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study. [PDF]

Ther Adv Med Oncol
Cho M, Park E, Lee YP, Kim H, Park HS, Kim HK, Yang Y, Kwon J, Hyeong Lee K, Han HS.   +9 more
europepmc   +1 more source

Erythropoiesis-stimulating agent responsiveness and hemoglobin variability is associated with fat tissue index in hemodialysis patients with darbepoetin-alfa treatment: a prospective observational cohort study. [PDF]

Kidney Res Clin Pract
Yu H, Oh DJ, Kim DH.
europepmc   +1 more source